iv Microtracer™

clinical-facilitiesivMicrotracer™ uses microdose levels of 14C-radiolabelled drug substance to investigate human pharmacokinetics (PK) as part of the early drug development programme. ivMicrotracer can be conducted as a standalone programme, or incorporated into any early development or human ADME study.


  • streamlines development of intravenous (IV) drug products
  • eliminates the need for supporting IV toxicology and local tolerability data
  • significantly decreases the consumption of drug substances and reduces timelines and cost.


Please enter your name and email to download the document

First Name (required)

Last Name (required)

Job Title (required)

Company (required)

City (required)

Country (required)

Your Email (required)